Outset Medical, Inc.
OMCIK 0001484612 · Electromedical & Electrotherapeutic Apparatus · Nasdaq
- Home Dialysis Plus, Ltd. (until 2011-02-25)
Revenue (TTM)
$118.47M
+5.1% YoY
Q1 May 2026
Net Income (TTM)
−$81.14M
+36.2% YoY
Q1 May 2026
EPS Diluted (TTM)
−$6.73
+85.5% YoY
Q1 May 2026
Gross Margin
39.4%
Q1 May 2026
Operating Margin
-55.7%
Q1 May 2026
Net Margin
-68.5%
Q1 May 2026
Free Cash Flow (TTM)
−$130.53M
Q1 May 2026
Cash
$30.56M
Q1 May 2026
Total Debt
$101.69M
Q1 May 2026
Shares Outstanding
18.54M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
Balance Sheet
Cash vs Debt
Latest news
All news →-
High Positive
Outset Medical (OM) Signs HCA Console Refresh Deal Through 2028
Outset Medical extended its Tablo hemodialysis supply agreement with HCA, committing to a fleet refresh of consoles through December 31, 2028.